guidelines:
  1: Reynolds_Risk_Score_for_CardiovascularRisk_in_Women_guideline.v1
test_cases:
- id: Score 1.4 
  input:
    1:
      gt0005|Age: 45,a
      gt0007|Systolic BP: 120,mm[Hg]
      gt0012|Diabetes mellitus: 1|local::at0006|Yes|
      gt0013|Current smoker: 1|local::at0009|Yes|
      gt0014|Parent with MI before age 60 years: 1|local::at0012|Yes|
      gt0018|Hemoglobin A1c(%): 4,1
      gt0021|HDL Cholesterol: 50,mg/dl
      gt0022|Total Cholesterol: 100,mg/dl
      gt0024|hsCRP: 3,mg/l
  expected_output:
    1:
      gt0011|10-year cardiovascular disease risk (%): 1.4
      gt0010|B score: 22.38
      gt0039|Recommendation: 0|local::at0008|Unclear evidence for statin therapy|


- id: Score 0.8
  input:
    1:
      gt0005|Age: 60,a
      gt0007|Systolic BP: 120,mm[Hg]
      gt0012|Diabetes mellitus: 0|local::at0005|No|
      gt0013|Current smoker: 0|local::at0008|No|
      gt0014|Parent with MI before age 60 years: 0|local::at0011|No|
      gt0018|Hemoglobin A1c(%): 4,1
      gt0021|HDL Cholesterol: 50,mg/dl
      gt0022|Total Cholesterol: 100,mg/dl
      gt0024|hsCRP: 3,mg/l
  expected_output:
    1:
      gt0011|10-year cardiovascular disease risk (%): 0.8
      gt0010|B score: 21.79
      gt0039|Recommendation: 0|local::at0008|Unclear evidence for statin therapy|

- id: Score 12.1 
  input:
    1:
      gt0005|Age: 70,a
      gt0007|Systolic BP: 160,mm[Hg]
      gt0012|Diabetes mellitus: 1|local::at0006|Yes|
      gt0013|Current smoker: 0|local::at0008|No|
      gt0014|Parent with MI before age 60 years: 1|local::at0012|Yes|
      gt0018|Hemoglobin A1c(%): 4,1
      gt0021|HDL Cholesterol: 60,mg/dl
      gt0022|Total Cholesterol: 120,mg/dl
      gt0024|hsCRP: 3,mg/l
  expected_output:
    1:
      gt0011|10-year cardiovascular disease risk (%): 12.1
      gt0010|B score: 24.50
      gt0039|Recommendation: 2|local::at0010|Discussion of lifestyle modification and initiation of statin therapy U.S. treatment guidelines recommend initiation of treatment with 10-year risk estimates >10%:Understanding patient preference and motivation and frank discussion with patients about the risks and benefits of statin therapy in reducing cardiovascular events such as stroke, MI, and CVA in female patients over the next ten years.|


- id: Score 27.3
  input:
    1:
      gt0005|Age: 70,a
      gt0007|Systolic BP: 160,mm[Hg]
      gt0012|Diabetes mellitus: 1|local::at0006|Yes|
      gt0013|Current smoker: 1|local::at0009|Yes|
      gt0014|Parent with MI before age 60 years: 1|local::at0012|Yes|
      gt0018|Hemoglobin A1c(%): 4,1
      gt0021|HDL Cholesterol: 60,mg/dl
      gt0022|Total Cholesterol: 120,mg/dl
      gt0024|hsCRP: 3,mg/l
  expected_output:
    1:
      gt0011|10-year cardiovascular disease risk (%): 27.3
      gt0010|B score: 25.32
      gt0039|Recommendation: 3|local::at0011|Strongly recommend statin therapy in conjunction with lifestyle modification|



